This study identified γδ T cells, in particular Vδ1 T cells, in AML and MM as expressors of multiple inhibitory receptors including TIGIT, PD-1, TIM-3, and the potential tissue residency marker CD39. The gene discussed is ENTPD1; the disease is acute myeloid leukemia.